BR9713280A - Derivados de naftiridina - Google Patents
Derivados de naftiridinaInfo
- Publication number
- BR9713280A BR9713280A BR9713280-2A BR9713280A BR9713280A BR 9713280 A BR9713280 A BR 9713280A BR 9713280 A BR9713280 A BR 9713280A BR 9713280 A BR9713280 A BR 9713280A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- processes
- naphthyridine derivatives
- new
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9622386.2 | 1996-10-28 | ||
GBGB9622386.2A GB9622386D0 (en) | 1996-10-28 | 1996-10-28 | Organic compounds |
PCT/EP1997/005898 WO1998018796A1 (en) | 1996-10-28 | 1997-10-24 | Naphthyridine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9713280A true BR9713280A (pt) | 1999-11-03 |
BR9713280B1 BR9713280B1 (pt) | 2010-12-14 |
Family
ID=10802050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9713280-2A BR9713280B1 (pt) | 1996-10-28 | 1997-10-24 | derivados de naftiridina, composiÇÕes farmacÊuticas, uso dos mesmos, bem como processo para sua preparaÇço. |
Country Status (32)
Country | Link |
---|---|
US (1) | US6136821A (pt) |
EP (1) | EP0934320B1 (pt) |
JP (1) | JP4451496B2 (pt) |
KR (1) | KR100524329B1 (pt) |
CN (1) | CN1103773C (pt) |
AR (1) | AR009128A1 (pt) |
AT (1) | ATE236155T1 (pt) |
AU (1) | AU724471B2 (pt) |
BR (1) | BR9713280B1 (pt) |
CA (1) | CA2269946C (pt) |
CO (1) | CO4910164A1 (pt) |
CZ (1) | CZ146699A3 (pt) |
DE (1) | DE69720493T2 (pt) |
DK (1) | DK0934320T3 (pt) |
ES (1) | ES2196377T3 (pt) |
GB (1) | GB9622386D0 (pt) |
HK (1) | HK1022305A1 (pt) |
HU (1) | HUP9904204A3 (pt) |
ID (1) | ID18623A (pt) |
IL (2) | IL129502A0 (pt) |
MY (1) | MY132642A (pt) |
NO (1) | NO312677B1 (pt) |
NZ (1) | NZ335363A (pt) |
PE (1) | PE10899A1 (pt) |
PL (1) | PL189280B1 (pt) |
PT (1) | PT934320E (pt) |
SI (1) | SI0934320T1 (pt) |
SK (1) | SK283562B6 (pt) |
TR (1) | TR199900920T2 (pt) |
TW (1) | TW399052B (pt) |
WO (1) | WO1998018796A1 (pt) |
ZA (1) | ZA979593B (pt) |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2359449A1 (en) | 1999-01-15 | 2000-07-20 | Beate Gutterer | Phenanthridine-n-oxides with pde-iv inhibiting activity |
ES2242594T3 (es) * | 1999-01-15 | 2005-11-16 | Altana Pharma Ag | N-oxidos de fenantridinas con una acitvidad inhidora de pde-iv. |
EP2193808A1 (en) | 1999-08-21 | 2010-06-09 | Nycomed GmbH | Synergistic combination |
US6953774B2 (en) | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
HUP0401305A2 (hu) | 2001-01-31 | 2004-10-28 | Pfizer Products Inc. | Tiazolil-, oxazolil-, pirrolil- és imidazolil-savamid-származékok, mint PDE4 izozimek inhibitorai és az ezeket tartalmazó gyógyszerkészítmények |
US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
JP2004520386A (ja) | 2001-01-31 | 2004-07-08 | ファイザー・プロダクツ・インク | Pde4アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体 |
PL364910A1 (en) | 2001-01-31 | 2004-12-27 | Pfizer Products Inc. | Ether derivatives useful as inhibitors of pde4 isozymes |
JP4510383B2 (ja) * | 2001-05-23 | 2010-07-21 | 田辺三菱製薬株式会社 | 軟骨疾患修復治療用組成物 |
IL161317A0 (en) * | 2001-10-16 | 2004-09-27 | Memory Pharm Corp | 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
MY130622A (en) * | 2001-11-05 | 2007-07-31 | Novartis Ag | Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
BRPI0117198B1 (pt) | 2001-12-14 | 2018-03-13 | Merck Serono S.A. | Usos de composição compreendendo um inibidor seletivo de uma isoforma 4 de fosfodiesterase |
NZ540138A (en) | 2002-11-19 | 2008-07-31 | Memory Pharm Corp | Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
GB0229281D0 (en) * | 2002-12-16 | 2003-01-22 | Novartis Ag | Organic compounds |
BRPI0410235A (pt) * | 2003-04-16 | 2006-05-09 | Memory Pharm Corp | inibição de pde4, composto, composição farmacêutica, método para efetuar a inibição da enzima pde4, incrementar a cognição e/ou tratar a psicose em um paciente, método para o tratamento de um paciente que tem uma doença que envolve nìveis de camp diminuìdos, método para o tratamento de um paciente que sofre de uma doença alérgica ou inflamatória e método para o tratamento de um paciente que sofre de neurodegeneração resultante de uma doença ou de um ferimento |
KR20060005375A (ko) * | 2003-04-18 | 2006-01-17 | 메모리 파마슈티칼스 코포레이션 | 포스포디에스테라제 4 억제제로서의 피라졸 유도체 |
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
MY141255A (en) | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
WO2006073413A1 (en) * | 2004-02-20 | 2006-07-13 | The Board Of Trustees Of The University Of Illinois | Blood pressure reduction in salt-sensitive |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
EP1758873A1 (en) * | 2004-06-22 | 2007-03-07 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
CA2577171A1 (en) * | 2004-09-14 | 2006-03-23 | Novartis Ag | Process for the preparation of 6, 8-substituted `1, 7 naphthpyridin derivatives by reacting the 8-halo-`1, 7 naphthpyridin-derivate with an organic boronic acid derivatives and intermadiates of this process |
CN101166733A (zh) | 2004-10-15 | 2008-04-23 | 记忆药物公司 | 作为磷酸二酯酶4抑制剂的吡唑衍生物 |
AU2005295350A1 (en) * | 2004-10-20 | 2006-04-27 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
JP2006241111A (ja) * | 2005-03-04 | 2006-09-14 | Univ Nihon | 新規ベンゾフロキサン及びその合成法 |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
JP2009512695A (ja) * | 2005-10-21 | 2009-03-26 | グラクソ グループ リミテッド | 化合物 |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
WO2007045477A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Human antibodies against il-13 and therapeutic uses |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
EP1963324B1 (en) | 2005-12-22 | 2010-04-21 | Glaxo Group Limited | Heterocyclic compounds, their preparation and their use as antibacterials |
GB0526244D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
GB0601951D0 (en) * | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
ATE549337T1 (de) | 2006-04-21 | 2012-03-15 | Novartis Ag | Purinderivate zur verwendung als adenosin-a2a- rezeptoragonisten |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
AU2007302263A1 (en) | 2006-09-29 | 2008-04-03 | Novartis Ag | Pyrazolopyrimidines as P13K lipid kinase inhibitors |
WO2008052734A1 (en) | 2006-10-30 | 2008-05-08 | Novartis Ag | Heterocyclic compounds as antiinflammatory agents |
JP2010515729A (ja) | 2007-01-10 | 2010-05-13 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
BRPI0811562A2 (pt) | 2007-05-07 | 2014-12-09 | Novartis Ag | Compostos orgânicos |
TWI439462B (zh) | 2007-12-10 | 2014-06-01 | Novartis Ag | 作為enac阻抑劑之螺環胍化合物 |
PT2231642E (pt) | 2008-01-11 | 2014-03-12 | Novartis Ag | Pirimidinas como inibidores de quinase |
US8268834B2 (en) | 2008-03-19 | 2012-09-18 | Novartis Ag | Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme |
CN102112130A (zh) | 2008-06-10 | 2011-06-29 | 诺瓦提斯公司 | 作为上皮钠通道阻滞剂的吡嗪衍生物 |
WO2010088335A1 (en) | 2009-01-29 | 2010-08-05 | Novartis Ag | Substituted benzimidazoles for the treatment of astrocytomas |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
BR112012003262A8 (pt) | 2009-08-12 | 2016-05-17 | Novartis Ag | compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação |
CN105078978A (zh) | 2009-08-17 | 2015-11-25 | 因特利凯公司 | 杂环化合物及其用途 |
WO2011020861A1 (en) | 2009-08-20 | 2011-02-24 | Novartis Ag | Heterocyclic oxime compounds |
EP2813227A1 (en) | 2009-10-22 | 2014-12-17 | Vertex Pharmaceuticals Incorporated | Compositions for treatment of cystic fibrosis and other chronic diseases |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
CN103097385B (zh) | 2010-07-14 | 2016-08-03 | 诺华股份有限公司 | Ip受体激动剂杂环化合物 |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
US20130324526A1 (en) | 2011-02-10 | 2013-12-05 | Novartis Ag | [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
JP5808826B2 (ja) | 2011-02-23 | 2015-11-10 | インテリカイン, エルエルシー | 複素環化合物およびその使用 |
CA2828219A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Pyrazolo [1,5-a] pyridines as trk inhibitors |
UY34305A (es) | 2011-09-01 | 2013-04-30 | Novartis Ag | Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar |
CA2848809A1 (en) | 2011-09-15 | 2013-03-21 | Novartis Ag | 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase |
WO2013038373A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
EP2755652B1 (en) | 2011-09-16 | 2021-06-02 | Novartis AG | N-substituted heterocyclyl carboxamides |
WO2013038381A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine/pyrazine amide derivatives |
WO2013038378A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
JP5886433B2 (ja) | 2011-09-16 | 2016-03-16 | ノバルティス アーゲー | 嚢胞性線維症処置のためのヘテロ環式化合物 |
EP2793893A4 (en) | 2011-11-23 | 2015-07-08 | Intellikine Llc | IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
TW201335160A (zh) | 2012-01-13 | 2013-09-01 | Novartis Ag | Ip受體激動劑之雜環化合物 |
US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
WO2013149581A1 (en) | 2012-04-03 | 2013-10-10 | Novartis Ag | Combination products with tyrosine kinase inhibitors and their use |
JP5907005B2 (ja) * | 2012-09-04 | 2016-04-20 | エヌ・イーケムキャット株式会社 | ビフェニル化合物の合成方法 |
JP5907006B2 (ja) * | 2012-09-04 | 2016-04-20 | エヌ・イーケムキャット株式会社 | ビフェニル化合物の合成方法 |
WO2014125413A1 (en) | 2013-02-13 | 2014-08-21 | Novartis Ag | Ip receptor agonist heterocyclic compounds |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
CN105246482A (zh) | 2013-03-15 | 2016-01-13 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
WO2015084804A1 (en) | 2013-12-03 | 2015-06-11 | Novartis Ag | Combination of mdm2 inhibitor and braf inhibitor and their use |
MX2016013812A (es) | 2014-04-24 | 2017-03-09 | Novartis Ag | Derivados de amino-pirazina como inhibidores de fosfatidil-inositol-3-cinasa. |
EA033571B1 (ru) | 2014-04-24 | 2019-11-06 | Novartis Ag | Производные пиразина в качестве ингибиторов фосфатидилинозитол 3-киназы |
WO2015162456A1 (en) | 2014-04-24 | 2015-10-29 | Novartis Ag | Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors |
US9741941B2 (en) | 2014-04-29 | 2017-08-22 | Universal Display Corporation | Organic electroluminescent materials and devices |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
WO2016016822A1 (en) | 2014-07-31 | 2016-02-04 | Novartis Ag | Combination therapy |
MX2021015133A (es) | 2019-06-10 | 2022-01-24 | Novartis Ag | Derivado de piridina y pirazina para el tratamiento de la fibrosis quistica, enfermedad pulmonar obstructiva cronica y bronquiectasia. |
JOP20220044A1 (ar) | 2019-08-28 | 2023-01-30 | Novartis Ag | مشتقات 1، 3- فينيل أريل غير متجانسة بها استبدال واستخدامها في معالجة مرض |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54138572A (en) * | 1978-04-17 | 1979-10-27 | Kyowa Hakko Kogyo Co Ltd | Novel isoquinoline derivative |
JPS57203068A (en) * | 1981-06-08 | 1982-12-13 | Teikoku Hormone Mfg Co Ltd | Novel 1-phenylisoquinoline derivative |
FR2567520B1 (fr) * | 1984-07-11 | 1987-01-02 | Carpibem | Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres |
JPS6230780A (ja) * | 1985-04-17 | 1987-02-09 | Ss Pharmaceut Co Ltd | 1,7−ナフチリジン誘導体及びこれを含有する薬剤 |
JPS6348277A (ja) * | 1986-08-19 | 1988-02-29 | Ss Pharmaceut Co Ltd | 8−ピペラジニル−1,7−ナフチリジン誘導体 |
GB8800397D0 (en) * | 1988-01-08 | 1988-02-10 | Sandoz Ltd | Improvements in/relating to organic compounds |
US4956371A (en) * | 1989-09-19 | 1990-09-11 | Euroceltique, S.A. | Substituted isoquinolines and methods of using same |
US5466697A (en) * | 1994-07-13 | 1995-11-14 | Syntex (U.S.A.) Inc. | 8-phenyl-1,6-naphthyridin-5-ones |
EP0970082A2 (en) * | 1997-02-18 | 2000-01-12 | Neurocrine Biosciences, Inc. | Biazacyclic crf antagonists |
-
1996
- 1996-10-28 GB GBGB9622386.2A patent/GB9622386D0/en active Pending
-
1997
- 1997-10-16 TW TW086115176A patent/TW399052B/zh not_active IP Right Cessation
- 1997-10-24 PE PE1997000953A patent/PE10899A1/es not_active Application Discontinuation
- 1997-10-24 PT PT97948803T patent/PT934320E/pt unknown
- 1997-10-24 SI SI9730541T patent/SI0934320T1/xx unknown
- 1997-10-24 CZ CZ991466A patent/CZ146699A3/cs unknown
- 1997-10-24 DK DK97948803T patent/DK0934320T3/da active
- 1997-10-24 CA CA002269946A patent/CA2269946C/en not_active Expired - Fee Related
- 1997-10-24 BR BRPI9713280-2A patent/BR9713280B1/pt not_active IP Right Cessation
- 1997-10-24 NZ NZ335363A patent/NZ335363A/xx unknown
- 1997-10-24 EP EP97948803A patent/EP0934320B1/en not_active Expired - Lifetime
- 1997-10-24 DE DE69720493T patent/DE69720493T2/de not_active Expired - Lifetime
- 1997-10-24 AT AT97948803T patent/ATE236155T1/de not_active IP Right Cessation
- 1997-10-24 US US09/297,245 patent/US6136821A/en not_active Expired - Fee Related
- 1997-10-24 WO PCT/EP1997/005898 patent/WO1998018796A1/en not_active Application Discontinuation
- 1997-10-24 AU AU69084/98A patent/AU724471B2/en not_active Ceased
- 1997-10-24 JP JP52002898A patent/JP4451496B2/ja not_active Expired - Fee Related
- 1997-10-24 ES ES97948803T patent/ES2196377T3/es not_active Expired - Lifetime
- 1997-10-24 CN CN97199186A patent/CN1103773C/zh not_active Expired - Fee Related
- 1997-10-24 SK SK557-99A patent/SK283562B6/sk unknown
- 1997-10-24 HU HU9904204A patent/HUP9904204A3/hu unknown
- 1997-10-24 AR ARP970104916A patent/AR009128A1/es unknown
- 1997-10-24 IL IL12950297A patent/IL129502A0/xx not_active IP Right Cessation
- 1997-10-24 TR TR1999/00920T patent/TR199900920T2/xx unknown
- 1997-10-24 PL PL97332738A patent/PL189280B1/pl not_active IP Right Cessation
- 1997-10-24 KR KR10-1999-7003661A patent/KR100524329B1/ko not_active IP Right Cessation
- 1997-10-27 ZA ZA9709593A patent/ZA979593B/xx unknown
- 1997-10-27 MY MYPI97005054A patent/MY132642A/en unknown
- 1997-10-27 ID IDP973530A patent/ID18623A/id unknown
- 1997-10-28 CO CO97063263A patent/CO4910164A1/es unknown
-
1999
- 1999-04-19 IL IL129502A patent/IL129502A/en unknown
- 1999-04-21 NO NO19991903A patent/NO312677B1/no unknown
-
2000
- 2000-02-11 HK HK00100828A patent/HK1022305A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9713280A (pt) | Derivados de naftiridina | |
ATE377597T1 (de) | Anilinochinazoline als protein-tyrosin- kinasehemmer | |
CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
PT1263725E (pt) | Novos compostos | |
BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
BR9811805A (pt) | Derivados quinazolina substituìda e seu uso como inibidores de quinase tirosina | |
BR9911013A (pt) | Derivados de pirazol como inibidores da p-38 map quinase | |
BR0012888A (pt) | Inibidores derivados de purina de proteìna tirosina sic quinase | |
BRPI0411582A (pt) | substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso | |
BR0312560A (pt) | Novas espiropiperidinas ou espiropirrolidinas tricìclicas | |
BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
BR9907886A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo de tratamento ou profilaxia de doenças inflamatórias, por exemplo asma ou copd. | |
ES2161418T3 (es) | Compuestos de piridilfurano y de piridiltiofeno y uso farmaceutico de los mismos. | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
TR200101412T2 (tr) | Yeni bileşikler. | |
DE69819360D1 (de) | Neue psoralene zur inaktivierung von pathogenen | |
BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
BRPI0110024B8 (pt) | derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
HUP0002427A2 (hu) | Leptin mint tumorsejt proliferációt gátló hatóanyag és alkalmazása | |
BR0015821A (pt) | Derivados de pirimidina | |
BR9801150A (pt) | Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos. | |
BRPI0418255A (pt) | derivados de piperazina e piperidina n-substituìdos | |
EA200000165A1 (ru) | Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: C07D 471/04, A61K 31/44 Ipc: A61K 31/4375 (2010.01), A61P 11/06 (2010.01), A61P |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/12/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A, 22A E 23A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |